investors

Nasdaq: Damien Perriman interview on NCT

66 views April 01, 2026

CCO at eXoZymes, Damien Perriman, interviewed at Nasdaq around our NCT project: "We’ve shown that...

investors

Interview: Cayman Chemical validates eXoZymes' technology...

278 views February 02, 2026

Using eXoZymes' tech transfer package, Cayman Chemical advanced the protocol from a one-liter...

investors

Rapid Scale-Up: Enzyme Breakthrough Achieved! (01)

21 views March 11, 2026

One of the biggest challenges of conventional technologies is the long timelines to advance...

Heltzen's updates

Nasdaq HERO

2,849 views February 18, 2026